CURIS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CURIS, INC. (CRIS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 115.99 thousand shares for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-02.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2023-11-02
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-09-30 was -1.46M shares, a 567.62% decline year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-06-30 was 451.85K shares, a 224.47% increase year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2023-03-31 was 1.13M shares, a 237.54% increase year-over-year.
- CURIS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-09-30 was 312.59K shares, a 6151.86% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month |
|---|---|---|---|
| 2023-09-30 | -1.46M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | -1.01M shares derived: sum of 2 quarters · filed 2023-11-02 | 115.99K shares 10-Q · filed 2023-11-02 |
| 2023-06-30 | 451.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | 1.58M shares 10-Q · filed 2023-08-03 | |
| 2023-03-31 | 1.13M shares 10-Q · filed 2023-05-04 | ||
| 2022-09-30 | 312.59K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 451.85K shares derived: sum of 2 quarters · filed 2022-11-09 | 785.41K shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 139.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 472.82K shares 10-Q · filed 2022-08-04 | |
| 2022-03-31 | 333.56K shares 10-Q · filed 2022-05-05 | ||
| 2021-09-30 | 5.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 72.50K shares derived: sum of 2 quarters · filed 2021-11-09 | 115.83K shares 10-Q · filed 2021-11-09 |
| 2021-06-30 | 67.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | 110.83K shares 10-Q · filed 2021-08-03 | |
| 2021-03-31 | 43.33K shares 10-Q · filed 2021-05-12 | ||
| 2020-09-30 | 33.31K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 326.38K shares derived: sum of 2 quarters · filed 2020-11-10 | 382.12K shares 10-Q · filed 2020-11-10 |
| 2020-06-30 | 293.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | 348.81K shares 10-Q · filed 2020-08-04 | |
| 2020-03-31 | 55.75K shares 10-Q · filed 2020-05-12 | ||
| 2019-09-30 | 291.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | 1.27M shares derived: sum of 2 quarters · filed 2019-11-05 | 1.58M shares 10-Q · filed 2019-11-05 |
| 2019-06-30 | 982.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | 1.29M shares 10-Q · filed 2019-08-09 | |
| 2019-03-31 | 304.31K shares 10-Q · filed 2019-05-14 | ||
| 2018-09-30 | 1.03M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | 633.36K shares derived: sum of 2 quarters · filed 2018-11-01 | 1.39M shares 10-Q · filed 2018-11-01 |
| 2018-06-30 | -395.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | 357.74K shares 10-Q · filed 2018-08-02 | |
| 2018-03-31 | 753.46K shares 10-Q · filed 2018-05-03 | ||
| 2017-09-30 | 1.67M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | 1.83M shares derived: sum of 2 quarters · filed 2017-11-07 | 2.09M shares 10-Q · filed 2017-11-07 |
| 2017-06-30 | 159.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | 417.75K shares 10-Q · filed 2017-08-03 | |
| 2017-03-31 | 258.00K shares 10-Q · filed 2017-05-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |